‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That
New York Times · LC · trust 37/100
A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.
Read the original at New York Times →
Open in TruthVane →